Neuroendocrine neoplasms (NENs) are derived from neuroendocrine cell system and can
have benign or malignant characteristics. They are rare tumors, but have been increasing in …

Gastrinomas are neuroendocrine neoplasms (NENs), that occur primarily in the duodenum
and pancreas, which ectopically secrete gastrin, resulting in the Zollinger-Ellison syndrome …

Continuous progress in the diagnostics and treatment of neuroendocrine neoplasms
(NENs), the emerging results of new clinical trials, and the new guidelines issued by medical …

Background Retrospective studies and single center experiences suggest a role of
capecitabine combined with temozolomide (CAPTEM) in neuroendocrine tumors (NENs) …

Survival for patients with aggressive pituitary tumours (APT) and pituitary carcinomas (PC)
has significantly improved following the increasing use of temozolomide (TMZ) since the first …

Introduction Recent classification of neuroendocrine neoplasms has defined well‐
differentiated high‐grade neuroendocrine tumors (NET G3) as a distinct entity from poorly …

Purpose Combinations of therapies may enhance therapeutic effects without significantly
increasing the incidence of adverse events. However, there are few data regarding survival …

Neuroendocrine tumors (NETs) are rare, heterogeneous, often indolent tumors that
predominantly originate in the lungs and gastrointestinal tract. An understanding of the …

Pancreatic neuroendocrine tumors (PNETs) are a heterogeneous and orphan group of
neoplasms that vary in their histology, clinical features, prognosis, and management. The …

Objective The primary aims of this study were to evaluate the long-term outcome of a
“sandwich chemo-PRRT (SCPRRT)” regimen with regard to therapeutic response rate …